- Home
- PROK vs BAER Comparison
PROK vs BAER Comparison
Compare PROK & BAER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- BAER
- Stock Information
- Founded
- PROK 2015
- BAER 2014
- Country
- PROK United States
- BAER United States
- Employees
- PROK N/A
- BAER N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- BAER Blank Checks
- Sector
- PROK Health Care
- BAER Finance
- Exchange
- PROK Nasdaq
- BAER Nasdaq
- Market Cap
- PROK 211.1M
- BAER 178.5M
- IPO Year
- PROK N/A
- BAER N/A
- Fundamental
- Price
- PROK $1.62
- BAER $2.55
- Analyst Decision
- PROK Buy
- BAER Strong Buy
- Analyst Count
- PROK 5
- BAER 1
- Target Price
- PROK $4.50
- BAER $6.00
- AVG Volume (30 Days)
- PROK 409.2K
- BAER 4.0M
- Earning Date
- PROK 03-21-2025
- BAER 03-18-2025
- Dividend Yield
- PROK N/A
- BAER N/A
- EPS Growth
- PROK N/A
- BAER N/A
- EPS
- PROK N/A
- BAER N/A
- Revenue
- PROK N/A
- BAER $84,136,000.00
- Revenue This Year
- PROK N/A
- BAER $41.90
- Revenue Next Year
- PROK N/A
- BAER $35.88
- P/E Ratio
- PROK N/A
- BAER N/A
- Revenue Growth
- PROK N/A
- BAER 26.12
- 52 Week Low
- PROK $1.18
- BAER $1.71
- 52 Week High
- PROK $4.44
- BAER $6.20
- Technical
- Relative Strength Index (RSI)
- PROK 45.03
- BAER 45.98
- Support Level
- PROK $1.57
- BAER $2.47
- Resistance Level
- PROK $1.77
- BAER $2.88
- Average True Range (ATR)
- PROK 0.13
- BAER 0.39
- MACD
- PROK -0.00
- BAER -0.04
- Stochastic Oscillator
- PROK 31.25
- BAER 16.26
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About BAER Bridger Aerospace Group Holdings Inc.
Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Bridger Aerospace provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation. The company's portfolio is organized across two offerings: Fire Suppression, which Consists of deploying specialized Viking CL-415EAF ("Super Scooper") aircraft to drop large amounts of water quickly and directly on wildfires, and Aerial Surveillance, providing aerial surveillance via manned aircraft for fire suppression aircraft.